Aspirin and Antiplatelet Drugs in the Prevention of Cardiovascular Complications of Diabetes
Keywords: Aspirin, antiplatelet drugs, myocardial infarction, stroke, bleeding.
KeywordsAntiplatelet Therapy Antiplatelet Drug Major Cardiovascular Event Early Treatment Diabetic Retinopathy Study Multiple Risk Factor Intervention Trial
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 4.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486–2497.Google Scholar
- 6.Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106.Google Scholar
- 8.Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group: Effects of aspirin treatment on diabetic retinopathy: ETDRS report number 8. Ophthalmology.1991;98(Suppl.):757–765.Google Scholar
- 11.The Medical Research Council's General Practice Research Framework. Thrombosis Prevention Trial: randomised trial of low-intensity oral anticoagulant with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998;351:233–241.CrossRefGoogle Scholar
- 13.Hansson L, Zanchetti A, Carruthers SG et al for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755–1762.CrossRefPubMedGoogle Scholar
© Springer Science+Business Media, LLC 2007